MHLW Clarifies Position on Investigational Drug Info; No Generic Names Allowed on Companies’ Clinical Trial Websites

February 2, 2022
Pharmaceutical companies should not post the generic names or development codes of their investigational drugs on their clinical trial websites intended for the general public as it runs afoul of the Pharmaceuticals and Medical Devices (PMD) Law, a health ministry...read more